Concepedia

Yuan Mi

YM

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

2006

Affiliations

Novartis (Switzerland)(Current)

Novartis (China)

Genomics Institute of the Novartis Research Foundation

Novartis (United States)

Fourth Hospital of Hebei Medical University

Yuan Mi is an author at Novartis (Switzerland) specializing in medicine, molecular oncology, and oncology.

Publications per year

2006–2024

9

Publications

9

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

Wei Qi, Homan Chan, Lin Teng et al. · Proceedings of the National Academy of Sciences · 2012 · 545 citations · Full text

, , +17

Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator

Shifeng Pan, Nathanael S. Gray, Wenqi Gao et al. · ACS Medicinal Chemistry Letters · 2013 · 169 citations · Full text

, , +9

A Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model

Shifeng Pan, Yuan Mi, Charles Pally et al. · Chemistry & Biology · 2006 · 127 citations

, , +12

Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy

Ying Huang, Jeff Zhang, Zhengtian Yu et al. · Journal of Medicinal Chemistry · 2017 · 103 citations · Full text

, , +17

Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models

Pam Albaugh, Yi Fan, Yuan Mi et al. · ACS Medicinal Chemistry Letters · 2012 · 96 citations · Full text

, , +15

1–5 of 9